(3)Applications for the renewal of the approval of those substances were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012note, repealed by Commission Implementing Regulation (EU) 2020/1740note. However, the procedure for the renewal of the approval of those active substances as set out in Commission Implementing Regulation (EU) No 844/2012 continues to apply in accordance with Article 17(2) of Commission Implementing Regulation (EU) 2020/1740.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.